Role and new insights of pirfenidone in fibrotic diseases DA Lopez-de la Mora, C Sanchez-Roque, M Montoya-Buelna, ... International journal of medical sciences 12 (11), 840, 2015 | 144 | 2015 |
A pilot study in patients with established advanced liver fibrosis using pirfenidone J Armendariz-Borunda, MC Islas-Carbajal, E Meza-Garcia, AR Rincón, ... Gut 55 (11), 1663-1665, 2006 | 106 | 2006 |
Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C L Flores-Contreras, AS Sandoval-Rodríguez, MG Mena-Enriquez, ... BMC gastroenterology 14, 1-11, 2014 | 95 | 2014 |
Roles of Nrf2 in liver diseases: molecular, pharmacological, and epigenetic aspects M Galicia-Moreno, S Lucano-Landeros, HC Monroy-Ramirez, ... Antioxidants 9 (10), 980, 2020 | 79 | 2020 |
A controlled clinical trial with pirfenidone in the treatment of pathological skin scarring caused by burns in pediatric patients J Armendariz-Borunda, I Lyra-Gonzalez, D Medina-Preciado, ... Annals of plastic surgery 68 (1), 22-28, 2012 | 70 | 2012 |
Liver cancer: therapeutic challenges and the importance of experimental models M Galicia-Moreno, JA Silva-Gomez, S Lucano-Landeros, A Santos, ... Canadian Journal of Gastroenterology and Hepatology 2021 (1), 8837811, 2021 | 51 | 2021 |
Controlled clinical trial with pirfenidone in the treatment of breast capsular contracture: association of TGF-β polymorphisms ER Veras-Castillo, L Cardenas-Camarena, I Lyra-Gonzalez, ... Annals of plastic surgery 70 (1), 16-22, 2013 | 51 | 2013 |
New gene therapy strategies for hepatic fibrosis AM Salazar-Montes, LD Hernández-Ortega, LL Martha S, ... Worl Journal of Gastroenterology 21 (13), 3813-3825, 2015 | 37 | 2015 |
Adenoviral delivery of dominant‐negative transforming growth factor β type II receptor up‐regulates transcriptional repressor SKI‐like oncogene, decreases matrix … A Marquez‐Aguirre, A Sandoval‐Rodriguez, J Gonzalez‐Cuevas, ... The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2009 | 33 | 2009 |
Pirfenidone accelerates wound healing in chronic diabetic foot ulcers: a randomized, double‐blind controlled trial LE Gasca-Lozano, S Lucano-Landeros, H Ruiz-Mercado, ... Journal of diabetes research 2017 (1), 3159798, 2017 | 32 | 2017 |
Epidemiologic, genetic, pathogenic, metabolic, epigenetic aspects involved in NASH-HCC: current therapeutic strategies J Gutiérrez-Cuevas, S Lucano-Landeros, D López-Cifuentes, A Santos, ... Cancers 15 (1), 23, 2022 | 30 | 2022 |
Fibrogenic polymorphisms (TGF-β, PAI-1, AT) in Mexican patients with established liver fibrosis. Potential correlation with pirfenidone treatment J Armendáriz-Borunda, AR Rincón, JF Muñoz-Valle, M Bueno-Topete, ... Journal of Investigative Medicine 56 (7), 944-953, 2008 | 28 | 2008 |
Pirfenidone prevents rat esophageal stricture formation J Orozco-Perez, O Aguirre-Jauregui, AM salazar-Montes, ... Journal of Surgical Research 194 (2), 558-564, 2015 | 21 | 2015 |
Association of genetic polymorphisms with histological grading of necroinflammation, staging of fibrosis, and liver function in Mexicans with chronic hepatitis C virus infection MG Sánchez-Parada, BA Alvarez-Rodríguez, BC Gómez-Meda, ... Journal of Investigative Medicine 61 (7), 1088-1096, 2013 | 16 | 2013 |
Hepatocarcinogenesis prevention by pirfenidone is PPARγ mediated and involves modification of nuclear NF-kB p65/p50 ratio JA Silva-Gomez, M Galicia-Moreno, A Sandoval-Rodriguez, ... International Journal of Molecular Sciences 22 (21), 11360, 2021 | 10 | 2021 |
Combinatorial gene therapy induces regression of hepatic encephalopathy FJ Gálvez-Gastélum, JJ Garcia-Bañuelos, C Beas-Zárate, ... Gene therapy 18 (1), 88-94, 2011 | 10 | 2011 |
Evaluation of Safety os a Newly Formulated Pirfenidone in Chronic Kidney Disease; A Non-Randomized Pilot Study in Mexican Patients SA Ojeda-Duran, I Lyra-González, A Meza-Rios, S Lucano-Landeros, ... Journal of Renal and Hepatic disorders 4 (1), 22-30, 2020 | 3 | 2020 |
Pirfenidone Protects from UVB-Induced Photodamage in Hairless Mice Y Martinez-Alvarado, E Amezcua-Galvez, J Davila-Rodriguez, ... Molecules 28 (7), 2929, 2023 | 1 | 2023 |
AdhMMP8 Vector Administration in Muscle: An Alternate Strategy to Regress Hepatic Fibrosis J García-Bañuelos, E Oceguera-Contreras, A Sandoval-Rodríguez, ... Cells 12 (17), 2127, 2023 | | 2023 |
PROLONGED-RELEASE PIRFENIDONE MODIFIES HEPATIC miRNAs EXPRESSION AND miRNA TARGET GENES IN A NASH EXPERIMENTAL MODEL R Escutia Gutierrez, J Samael Rodriguez-Sanabria, A Monraz Mendez, ... HEPATOLOGY 72, 345A-346A, 2020 | | 2020 |